Which age group with definite and possibly severe glaucoma typically warrants aggressive IOP lowering to reduce lifetime visual disability?

• A. Older patients
• B. Younger patients
• C. Pediatric patients
• D. Middle-aged patients

Answer: (B)

The main idea is that the benefit of lowering IOP is greatest when there are many years of life ahead in which glaucoma could progress. Younger patients have a much longer remaining lifespan, so they face a higher lifetime risk of irreversible visual disability if the disease progresses. Because of that, lowering IOP aggressively in those with definite and potentially severe glaucoma helps preserve vision over decades, making a lower, more ambitious target appropriate despite the burden of treatment. In contrast, older individuals have fewer years left for glaucoma to cause disability, so the urgency for aggressive lowering is typically less, and management focuses on balancing benefit with treatment burden and comorbidities. Pediatric cases require their own specialized considerations, but the question emphasizes the broader younger group, where the long horizon makes intensive IOP reduction particularly impactful.